Effects of calcium blockers on the cytosolic calcium, H2O2 production and elastase release in human neutrophils

Pharmacology and Toxicology

Volumn 79, Issue 6, 1996, Pages 312-317

  Haga, Yoshiyuki ^a   Dumitrescu, Alexandra ^a   Zhang, Yu ^a   Stain Malmgren, Rigmor ^a   Sjöquist, Per Ove ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; ELASTASE; FELODIPINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HYDROGEN PEROXIDE; NIMODIPINE; PHORBOL 13 ACETATE 12 MYRISTATE; VERAPAMIL;

ARTICLE; CONTROLLED STUDY; CYTOSOL; ENZYME RELEASE; GRANULOCYTE; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0030457944     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb00015.x     Document Type: Article

References (30)

1. 2+ influx across the plasma membrane of human neutrophils. Mol. Pharmacol. 1986, 30, 437-443.
2. Barrett, A. J.: Leukocyte elastase. Meth. Enzymol 1981, 80, 581-588.
3. Björkman, J.-A., L. Ek, D. Gustafsson, B. Ljung & M. Nordlander: Acute haemodynamic effects of felodipine, verapamil and hydralazine in the anaesthetized dog. Pharmacology & Toxicology 1991, 68, 310-315.
4. Castagna, M., Y. Takai, K. Kaibuchi, K. Sano, U. Kikkawa & T. Nishizuka: Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem. 1982, 257, 7847-7851.
5. 2+ concentrations and the effect of TMB-8. Biochim. Biophys. Acta 1986, 882, 57-62.
6. 2+ changes, cyclic AMP and protein kinase C. Biochim. Biophys. Acta 1985, 845, 223-236.
7. 2+ concentration. Biochem. J. 1985, 229, 361-367.
8. Elferink, J. G. R. & M. Deierkauf: Felodipine-induced inhibition of polymorphonuclear leukocyte functions. Biochem. Pharmacol. 1988, 37, 503-509
9. Engler, R. L., M. D. Dahlgren, D. D. Morris, M. A. Peterson & G. W. Schmid-Schönbein: Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Amer. J. Physiol. 1986, 251, H314-H322.
10. Filep, J. G. & E. Földes-Filep: Inhibition by calcium channel blockers of the binding of platelet-activating factor to human neutrophil granulocytes. Eur. J. Pharmacol. 1990, 190, 67-73.
11. Go, L. D., C. E. Murry, V. J. Richard, G. R. Weischedel, R. B. Jennings & K. A. Reimer: Myocardial neutrophil accumulation during reperfusion and reversible or irreversible ischemic injury. Amer. J. Physiol. 1988, 255, H1188-H1198.
12. Haga, Y., N. Hatori, M. Nordlander, R. Nordlander, P.-O. Sjöquist & L. Rydén: Coronary venous retroinfusion of felodipine reducing infarct size without affecting regional myocardial blood flow. Eur. Heart. J. 1993, 14, 1386-1393.
13. Haga, Y., Y. Uriuda, J.-A. Björkman, N. Hatori, L. Johansson, R. Nordlander, P.-O. Sjöquist & L. Rydén: Ischemic and nonischemic tissue concentrations of felodipine after coronary venous retroinfusion during myocardial ischemia and reperfusion: an experimental study in pigs. J. Cardiovasc. Pharmacol. 1994, 24, 298-302.
14. Hatori, N., Y. Haga, P.-O. Sjöquist, M. Nordlander & L. Rydén: Coronary venous retroinfusion of felodipine reduces myocardial necrosis after coronary occlusion and reperfusion. J. Cardiovasc. Pharmacol. 1993, 22, 160-166.
15. Johnson, P., J. A. Ware, P. B. Cliveden, M. Smith, A. M. Dvorak & E. W. Salzman: Measurement of ionized calcium in blood platelets with the photoprotein aequorin. J. Biol. Chem. 1985, 260, 2069-2076.
16. Klein, H., M. Schubothe, K. Nebendahl & H. Kreuzer: The effect of two different diltiazem treatments on infarct size in ischemic, reperfused porcine hearts. Circulation 1984, 69, 1000-1005.
17. Knabb, R., T. Rosamond, K. Fox, B. Sobel & S. Bergmann: Enhancement of salvage of reperfused ischemic myocardium by diltiazem. J. Amer. Coll. Cardiol. 1986, 8, 861-871.
18. Korchak, H. M., L. E. Rutherford & G. Weissmann: Stimulus response coupling in the human neutrophil. I. Kinetic analysis of changes in calcium permeability. J. Biol. Chem. 1984, 259, 4070-4075.
19. Korchak, H. M., K. Vienne, L. E. Rutherford, C. Wilkenfeld, M. C. Finkelstein & G. Weissmann: Stimulus response coupling in the human neutrophils. II. Temporal analysis of changes in cytosolic calcium and calcium efflux. J. Biol. Chem. 1984, 259, 4076-4082.
20. Lew, P., C. Wollheim, R. Seger & T. Pozzan: Cytosolic free calcium changes induced by chemotactic peptide in neutrophils from patients with chronic granulomatous disease. Blood 1984, 63, 231-233.
21. Lucchesi, B. R.: Myocardial ischemia, reperfusion and free radical injury. Amer. J. Cardiol. 1990, 65, 141-231.
22. 2+-transients. Thromb. Haemost. 1992, 68, 352-356.
23. Marks, P. W. & F. R. Maxfield: Local and global changes in cytosolic free calcium in neutrophils during chemotaxis and phagocytosis. Cell. Calcium. 1990, 11, 181-190.
24. Nayler, W.: Second generation of calcium antagonists. Springer-Verlag, Heidelberg, Germany, 1991.
25. Opie, L. H.: Reperfusion injury and its pharmacologic modification. Circulation 1989, 80, 1049-1062.
26. Romson, J. M., B. G. Hook, S. L. Kunkel, G. D. Abrams, A. Schork & B. R. Lucchesi: Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983, 67, 1016-1023.
27. Simchowitz, L. & I. Spilberg: Generation of superoxide radicals by human peripheral neutrophils activated by chemotactic factor. Evidence for the role of calcium. J. Lab. Clin. Med. 1979, 93, 583-593.
28. Simpson, P. J., R. F. Todd, J. C. Fantone, J. K. Michelson, J. D. Griffin & B. R. Lucchesi: Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (Anti-Mol, Anti-CD11b) that inhibits leukocyte adhesion. J. Clin. Invest. 1988, 81, 624-629.
29. Ware, J. A., P. C. Johnson, M. Smith & E. W. Salzmann: Aequorin detects increased cytoplasmic calcium in platelets stimulated with phorbol ester or diacylclycerol. Biochem. Biophys. Res Com. 1985, 133, 98-104.
30. 2 produced by human neutrophils during the respiratory burst. Anal. Biochem. 1987, 165, 371-378.